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Feline diabetes mellitus: background 
 
Eric Zini 
 
Epidemiology 
Genetics 
A breed predisposition for diabetes mellitus (DM) is demonstrated in cats and supports the 
hypothesis of a genetic component in the pathogenesis of the disease. In particular, in Burmese 
cats one in 50 develops the disease whereas in domestic cats the frequency is only one in 200. 
The predisposition in Burmese is not sex linked or dominant (Henson et al. 2006). Other breeds at 
increased risk of developing DM are Russian Blue, Norwegian Forest cat, and Abyssinian. 
 
Obesity 
Obesity in cats is generally defined as a 30% excess of body weight above normal; overweight 
animals are 10% to 15% above normal. In practice it is often preferable to use a body condition 
score (BCS) system to classify body condition and define overweight and obesity in cats. The 
prevalence of overweight cats, evaluated with BCS systems, is estimated to vary between 6% and 
52%. Increased body weight predisposes cats to the development of insulin resistance and DM 
(Zoran et al. 2010). 
 
Neutering 
Neutering induces changes in basal metabolism and is one of the major risk factors for feline 
obesity. Both male and female cats increase their food intake and body fat mass following 
neutering. Alterations in sex hormones influence brain centers important for the control of food 
intake and metabolic rate and may result in increased energy intake and positive energy balance 
(Kanchuk et al. 2003). It has been demonstrated that gonadectomy removes the estrogenic 
inhibition of eating in female rodents and that these changes are reversed by estradiol treatment. A 
similar mechanism might explain obesity in neutered cats. 
 
Pathogenesis of DM in cats 
Insulin resistance 
Inflammatory conditions may be an independent risk factor for insulin resistance and DM in cats. 
Burmese cats with chronic or recurring periodontal disease have impaired glycemic control and are 
more prone to develop diabetes. In obese cats, insulin sensitivity is typically decreased by more 
than 50% compared to healthy lean animals. In fact, each kilogram of weight gain reduces insulin 
sensitivity and glucose effectiveness in cats by 30% (Hoenig et al. 2007). Insulin resistance in 
diabetic and non-diabetic cats can therefore be reversed by reducing body weight. Interestingly, 
obese male cats have lower innate insulin sensitivity and higher basal insulin concentrations; this 
may therefore be one factor explaining why obese male cats are more prone to DM than obese 
females. 
 
Glucotoxicity and lipotoxicity 
In healthy cats, 10-day infusion of glucose or lipids were administered to mimic the milieu of DM. 
Severe β-cell dysfunction was rapidly induced by sustained hyperglycemia, resulting in β-cell 
exhaustion and decreased insulin gene expression (Zini et al. 2009). Furthermore, hyperglycemia 
caused β-cell loss due to apoptosis that was not compensated by increased β-cell proliferation. In 
contrast to the detrimental effects of sustained hyperglycemia, hyperlipidemia did not affect basal 
insulin levels or glucose-stimulated insulin secretion in healthy cats. Conflicting results have been 
described with regard to the effects of excess lipids on insulin secretion. Studies in rats and 
humans reported increased, decreased or unchanged β-cell function. Hence, to date, glucotoxicity 
might have a primary role during the progression of DM in cats. 
 
Amyloid deposition 
More than 80% of diabetic cats appear to have pancreatic amyloid deposition (Figure 1). 
Depending on the extent of amyloidosis in diabetic cats, this seems to be associated with an 
approximately 50% loss of β-cells mass (Ma et al. 1998). β-cell vacuolar degeneration, chronic 
pancreatitis and a reduced number of islets or β-cells are other common histological findings in 
diabetic cat. However, not all cats with amyloid deposits develop diabetes and amyloid deposits 
are also present in non-diabetic cats. In agreement with these findings, the mean amyloid-positive 
cross-sectional area in the pancreatic samples of diabetic cats did not differ from matched control 
cats in a recent investigation (Zini et al. 2016). Deposition of amyloid is commonly believed to 
occur only in the extracellular compartment (i.e., within the islets but outside the β-cells). Based on 
a recent investigation in diabetic cats, aggregates of amylin fibrils or oligomers can be identified 
also within β-cells (Figure 2). This observation may point towards a role of intracellular deposition 
in the pathogenesis of β-cell failure (Zini et al. 2017). 
 
Inflammation and insulin resistance 
Inflammation, particularly in adipose tissue, has been causally linked to diet- and obesity-related 
insulin resistance and to the development of type 2 DM in several human and rodent studies. 
 
Adipokines and adipocytokines 
Similar to humans, secretion of adipokines like leptin and adiponectin from adipose tissue has 
been shown in cats (Radin et al. 2009). Higher circulating concentrations of leptin positively 
correlate with insulin resistance; it was claimed that this may even occur independent of changes 
in BCS and fat mass. The association between increased leptin levels and neutering is most 
probably related to the increase in fat mass gained post-neutering. However, a causal inter-
relationship between leptin, insulin resistance and diabetes has not been demonstrated in cats. 
In cats, adiponectin is produced and secreted exclusively by mature adipocytes; its gene 
expression is significantly higher in visceral than other adipose depots. Recent reports showed that 
the high molecular weight (HMW) multimers of adiponectin account for about 80% of total 
adiponectin in cats. HMW multimers are more closely associated with insulin sensitivity and body 
fat mass than total adiponectin. Plasma adiponectin concentrations negatively correlate with 
increases in fat mass, and circulating levels of adiponectin are significantly lower in obese than in 
normal-weight cats. Further, it seems that total adiponectin levels are lower in obese neutered 
male than in female cats, although this gender difference may not be directly attributable to sex 
hormones levels. The role of adiponectin as anti-inflammatory adipokine has not been investigated 
in cats.  
Several studies in cats have shown that TNF-α expression in adipose tissue and in skeletal muscle 
is increased in obese cats (Hoenig et al. 2006). However, there is a lack of published data 
regarding the circulation patterns of adipose-derived TNF-α and other cytokines in cats, probably 
due to the unavailability of reliable assays. Gene expression of insulin signaling-related genes is 
decreased in insulin sensitive tissues of obese cats. For instance, obese cats have decreased 
GLUT4 expression in muscle and fat, and IRS-2 mRNA levels are lower in skeletal muscle and 
liver. 
 
Inflammation and nutrient metabolism 
Subacute inflammation was induced by lipopolysaccharide (LPS) infusion in healthy cats, in the 
absence of obesity (Osto et al. 2011). This manipulation was sufficient to cause a transient insulin 
resistance state at the whole-body level, and a long-lasting peripheral and tissue-specific insulin 
resistance in cats; both effects were observed without significant effects on pancreatic β-cell 
function. LPS infusion also led to an increase of circulating and tissue markers of inflammation in 
cats. Further, mRNA and protein analysis revealed that expression of key genes involved in 
glucose, lipid and insulin metabolism were altered in a manner consistent with a tissue-specific 
reduction in insulin sensitivity. Major changes were observed in adipose tissue and in particular in 
the subcutaneous fat depot. This included a reduced adipocyte size due to increased hormone 
sensitive lipase activity, decreased high density lipoprotein cholesterol levels and increased 
triglyceride levels in plasma and liver; all changes pointed to severe dyslipidemia. The observation 
that adipocyte size in both fat depots of LPS-infused cats was significantly decreased and that 
subcutaneous compared to visceral fat was found to exhibit a much higher expression of pro-
inflammatory factors was particularly noteworthy. In fact, recent findings showed that in addition to 
adipose mass and distribution, mean fat cell size is associated with metabolic complications such 
as insulin resistance and adipose tissue inflammation in humans. Further, it has been 
demonstrated that an increased proportion of small adipose cells in human subcutaneous adipose 
tissue is associated with inflammation, independently of body mass index and insulin resistance. 
Whether such factors play a role in cats is currently unknown. 
 
Inflammation and β-cell function 
Interestingly, both experimental hyperglycemia and hyperlipidemia induced a systemic 
inflammation in healthy cats which resembled that observed in human T2DM. However, in contrast 
to the findings in humans, local inflammatory reactions in the islets were not observed after the 
hyperglycemic or hyperlipidemic clamps in cats. Hence, although hyperglycemia (but not 
hypertriglyceridemia) has detrimental effects on the endocrine pancreas, these effects did not 
seem to depend on the activation of local inflammatory responses, at least during 10-day infusions 
of glucose or lipids, respectively. It was also demonstrated that β-cell function was impaired during 
the initial days of endotoxin infusion but that this effect was no longer detectable by day 10 of the 
infusion. 
Recently, it was assessed whether diabetic cats have pathological evidence of islet inflammation or 
pancreatitis and found that the average counts of neutrophils, T- and B-lymphocytes in the islets 
did not differ between diabetic and healthy cats although the presence of lymphocytes in general 
tended to be more frequent in diabetic than control cats (Zini et al. 2016). In addition, a subset of 
diabetic cats showed lymphocytic infiltration of the islets that might contribute to β-cell loss. These 
results confirm previous observations that loss of β-cells occurs in diabetic cats and suggest that 
increased necrosis and fibrosis of the exocrine tissue may be associated with pancreatitis in at 
least some diabetic cats. 
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Figure 1. 
 
Pancreatic islet of a diabetic cat with large deposits of amyloid. Light microscopy, Congo red 
staining. 
 
 
Figure 2. 
 
Amylin aggregates in the cytoplasm of a β-cell in a diabetic cat; the red arrows show labeling of 
amorphous material with amylin antibodies (black dots). Electron microscopy, amylin-immunogold. 
